Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Reported Research Benefits Primarily used in preclinical research for its effects on muscle hypertrophy, skeletal muscle regeneration, recovery from injury, insulin sensitivity studies, and investigations into aging mechanisms
Eylea (aflibercept) Disease area(s): Ophthalmology Manufacturer(s): Regeneron/Bayer 2024 Sales (USD): $9.55 billion Why it sold so well: Eylea registered strong sales in 2024, driven by the introduction of Eylea HD, which received FDA approval in 2023 and is an 8 mg formulation offering extended dosing intervals for retinal diseases
This personalized approach ensures an optimal balance in harnessing the benefits of these injections over time
Short for Body Protection Compound, BPC-157 is a 15-amino acid fragment derived from proteins naturally found in human gastric juices
The Impact of Nutrition and Environmental Epigenetics on Human Health and Disease
GLP-1 compounds, however, present a unique problem
